Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS at the regional hospital of Sokodé, Togo

BMC Public Health

Palokinam Pitche⁵  Koussake Kombaté⁴  Akouda Akessiwe Patassi²  Mathias Kouamé N’Dri⁷  Abdoul-samadou Aboubakari¹  Peter Wasswa³  P’Niwè Massoubayo Patchali⁶  Bayaki Saka⁴  Dadja Essoya Landoh⁸  Issifou Yaya⁷ 

[1] Service de gynéco-obstétrique, CHU- Kara, Kara, Togo;Service des Maladies Infectieuses et de Pneumologie, CHU Sylvanus Olympio, Lomé, Togo;African Field Epidemiology Network (AFENET), Kampala, Uganda;Service de dermatologie et IST, CHU Sylvanus Olympio, Université de Lomé, Lomé, Togo;Conseil National de Lutte contre les IST/VIH/Sida, Lomé, Togo;Centre Hospitalier Régional (CHR) de Sokodé, Service de dispensation d’antirétroviraux (ARV), Sokodé, Togo;Laboratoire de Santé Publique (EA 3279), Aix-Marseille Université, Marseille, France;Division de l’Epidémiologie, Ministère de la Santé. S/C INH - Togo, BP 1396 Lomé, Togo

关键词: Togo;    People Living With HIV/AIDS;    Adherence to ART;   

Others  :  1091595
DOI  :  10.1186/1471-2458-14-1308

 received in 2014-08-14, accepted in 2014-12-16,  发布年份 2014

【 摘 要 】

Background

Adherence to antiretroviral therapy (ART) is beneficial in reducing the risk of emergence of HIV resistant strains. Adherence to ART among Persons Living with HIV/AIDS (PLWHA) is influenced by several factors related to the patient, the medication, and health facilities. In Togo, previous studies on adherence to ART have reported good adherence to ART during the first year of follow-up. However these may hide many disparities dues to cultural specificities which may differ across geographic areas of the country. We sought to determine the level of adherence to ART and document the associated factors among PLWHA at the regional hospital of Sokodé, Togo.

Methods

This was an analytical cross-sectional study conducted from May to July 2013 at the regional hospital of Sokodé among 291 PLWHA who had been on ART for at least three months before the study.

Results

A total of 291 PLWHA on ART were enrolled in the study. The mean age (±SD) was 37.3 ± 9.3 years and the sex ratio (Male/Female) was 0.4. Among them, 195 (67.0%) were living with their partners and 210 (72.2%) had formal education. Two-thirds (194/291; 66.7%) of the PLWHA interviewed lived in urban areas. The global adherence to ART was 78.4%; the factors associated with ART adherence were: level of education (aOR = 3.54; p = 0.027), alcohol consumption (aOR = 0.43; p = 0.033), ART perception (aOR = 2.90; p = 0.026) and HIV status disclosure to sexual partner (aOR = 7.19; p ≤ 0.001).

Conclusion

Although the level of adherence to ART in this study was higher than those reported in some studies in Sub-Saharan Africa, it remains sub-optimal and needs improvement. This may therefore hinder the implementation of efficient interventions related to access to ART services.

【 授权许可】

   
2014 Yaya et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]ONUSIDA: Rapport mondial : Rapport ONUSIDA sur l’épidémie mondiale de sida 2013. Genève: ONUSIDA; 2013.
• [2]ONUSIDA: Traitement 2015. Genève: ONUSIDA; 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/JC2484_treatment-2015_fr.pdf webcite, consulté le 26 avril 2014
• [3]Peretti-Watel P, Spire B, Schiltz MA, Bouhnik AD, Heard I, Lert F, Obadia Y: Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med 2006, 62:2420-2433.
• [4]Pennap GR, Abdullahi U, Bako IA: Adherence to highly active antiretroviral therapy and its challenges in people living with human immunodeficiency virus (HIV) infection in Keffi, Nigeria. J AIDS HIV Res 2013, 5:52-58.
• [5]Meresse M, March L, Kouanfack C, Bonono R-C, Boyer S, Laborde-Balen G, Aghokeng A, Suzan-Monti M, Delaporte E, Spire B, Carrieri MP, Laurent C: Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon. HIV Med 2014. doi:10.1111/hiv.12140
• [6]Faure N, Diafouka M, Nzounza P, Ekat MH, Mahambou ND, Levasseur G, Tattevin P, Mouala C, Simon B, Mattei JF: Observance thérapeutique des personnes vivant avec le VIH en 2009 au centre de traitement ambulatoire de Brazzaville, Congo. Med Trop 2011, 71:487-491.
• [7]Oku AO, Owoaje ET, Ige OK, Oyo-ita A: Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria. BMC Infect Dis 2013, 13:401. BioMed Central Full Text
• [8]Obirikorang C, Selleh PK, Abledu JK, Fofie CO: Predictors of Adherence to Antiretroviral Therapy among HIV/AIDS Patients in the Upper West Region of Ghana. ISRN AIDS 2013. http://dx.doi.org/10.1155/2013/873939 webcite
• [9]Bastard M, Fall MBK, et le groupe d’étude de la cohorte ANRS 1215: Observance à long terme au traitement antiretroviral au Sénégal. Bull Soc Pathol Exot 2014. doi:10.1007/s13149-014-0346-9
• [10]Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye AE, Osagbeni GK: Prevalence and determinants of non adherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infec Dev C’tries 2008, 2:369-372.
• [11]Li L, Lee S-J, Wen Y, Lin C, Wan D, Jiraphongsa C: Antiretroviral Therapy Adherence among Patients living with HIV/AIDS in Thailand. Nurs Health Sci 2010, 12:212-220.
• [12]Wakibi SN, Ng’ang’a ZW, Mbugua GG: Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res Ther 2011, 8:43. BioMed Central Full Text
• [13]Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S: Adherence to antiretroviral therapy among people living with HIV. North Am J Med Sci 2013, 5:220-223.
• [14]Musumari PM, Wouters E, Kayembe PK, KiumbuNzita M, Mbikayi SM, Suguimoto SP, Techasrivichien T, Lukhele BW, El-Saaidi C, Piot P, Ono-Kihara M, Kihara M: Food Insecurity Is Associated with Increased Risk of Non-Adherence to Antiretroviral Therapy among HIV-Infected Adults in the Democratic Republic of Congo: A Cross-Sectional Study. PLoS One 2014, 9(1):e85327.
• [15]Chesney MA: Factors Affecting Adherence to Antiretroviral Therapy. Clin Infect Dis 2000, 30(Supplement 2):S171-S176.
• [16]Balcha TT, Jeppsson A, Bekele A: Barriers to antiretroviral treatment in Ethiopia: a qualitative study. J Int Assoc Physicians AIDS Care 2011, 10:119-125.
• [17]Programme National de Lutte contre le Sida et les IST au Togo: Rapport d'activités 2012. Lomé: PNLS - Togo; 2013:99.
• [18]Saka B, Landoh DE, Kombaté K, Mouhari-Toure A, Makawa MS, Patassi A, Avodagbe LB, Aho K, Singo A, Pitche P: Évaluation du traitement antirétroviral de 1620 personnes infectées par le VIH au Togo. Med Sante Trop 2012, 22:193-197.
• [19]Ministère de la santé: Plan national de développement sanitaire 2012–2015. Lomé: Ministère de la Santé; 2012.
• [20]Yaya I, Saka B, Landoh ED, Patchali PM, Makawa MS, Senanou S, Idrissou D, Lamboni B, Pitche P: Sexual risk behavior among people living with HIV/AIDS on antiretroviral therapy at the regional hospital of Sokodé, Togo. BMC Public Health 2014, 14:636. doi:10.1186/1471-2458-14-636 BioMed Central Full Text
• [21]Costagliola D, Barberousse C: Comment mesurer l’observance? In L’observance aux traitements contre le VIH/sida: mesure, déterminants, évolution. Edited by ANRS. Paris: ANRS, Collection Sciences Sociales et Sida; 2001:33-42.
• [22]Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK: Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association “Espoir Vie Togo” in Togo, West Africa. BMC Clin Pharmacol 2010, 10:11.
• [23]Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML: High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013, 339:966-971.
• [24]Alagaw A, Godana W, Taha M, Dejene T: Factors associated with Antiretroviral Treatment Adherence among Adult Patients in WolaitaSoddo Hospital, Wolaita Zone, Southern Ethiopia. Sci J Public Health 2014, 2:69-77.
• [25]Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E: Factors influencing adherence to antiretroviral treatment in Nepal: A mixed-methods study. PLoS One 2012, 7:e35547.
• [26]Jaquet A, Ekouevi DK, Bashi J, Aboubakrine M, Messou E, Maiga M, Traore HA, Zannou MD, Guehi C, Ba-Gomis FO, Minga A, Allou G, Eholie SP, Bissagnene E, Sasco AJ, Dabis F: Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. Addiction 2010, 105:1416-1421.
• [27]Kalichman SC, Catz S, Ramachadran B: Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged of education. J Natl Med Assoc 1999, 9:439-441.
• [28]Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, Schelp FP: Adherence to Antiretroviral Therapy (ART) among People Living With HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health 2013, 13:617. BioMed Central Full Text
• [29]Hendershot C, Stoner S, Pantalone D, Simoni J: Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009, 52:180-202.
• [30]Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR: Adherence to Antiretroviral Therapy in Sub-Saharan African and North America – A meta analysis. JAMA 2006, 296:679-690.
• [31]Kip E, Ehlers VJ, Van Der Wal DM: Patients adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh 2009, 41:149-157.
• [32]Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM: Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav 2003, 7:61-72.
• [33]Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC: Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 2003, 15:217-230.
• [34]Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, McGibbon CA, Davis SM: Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud 2008, 45:1757-1763.